A detailed history of Kistler Tiffany Companies, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 1,824 shares of CRL stock, worth $360,696. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,824
Previous 1,572 16.03%
Holding current value
$360,696
Previous $317,000 20.82%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

BUY
$183.71 - $210.25 $46,294 - $52,983
252 Added 16.03%
1,824 $383,000
Q1 2023

May 03, 2023

BUY
$191.89 - $259.92 $131,060 - $177,525
683 Added 76.83%
1,572 $317,000
Q4 2022

Jan 27, 2023

BUY
$197.11 - $250.07 $157,490 - $199,805
799 Added 887.78%
889 $193,000
Q3 2022

Nov 09, 2022

BUY
$182.44 - $250.54 $16,419 - $22,548
90 New
90 $18,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.